Cardiac implantable electronic and other monitoring devices in continuous-flow left ventricular assist device patients. A clinical consensus statement of the Heart Failure Association and the European Heart Rhythm Association of the ESC

Offer Amir; Stamatis Adamopoulos; Haran Burri; Antoni Bayes-Genis; Christophe Leclercq; Maja Cikes; Anastasia Egorova; Petr Peichl; Marat Fudim; Archana Rao; Finn Gustafsson; Sergio Richter; Matteo Pagnesi; Giuseppe Rosano; Frank Ruschitzka; Jens Cosedis Nielsen

doi:10.1002/ejhf.3635

Cardiac implantable electronic and other monitoring devices in continuous-flow left ventricular assist device patients. A clinical consensus statement of the Heart Failure Association and the European Heart Rhythm Association of the ESC

Offer Amir
, Stamatis Adamopoulos
, Haran Burri
, Antoni Bayes-Genis
, Christophe Leclercq
, Maja Cikes
, Anastasia Egorova
, Petr Peichl
, Marat Fudim
, Archana Rao
, Finn Gustafsson
, Sergio Richter
, Matteo Pagnesi
, Giuseppe Rosano
, Frank Ruschitzka
, Jens Cosedis Nielsen

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

The management of heart failure patients with continuous-flow left ventricular assist device (LVAD) patients is challenging. While one third of these patients are recipients of cardiac implantable electronic devices (CIEDs), the risk for atrial and ventricular arrhythmias may coexist. The lack of large datasets and dedicated randomized controlled trials (RCTs) focusing on LVAD and CIED implantation and management has brought medical centres to develop their own protocols and guidelines. This clinical consensus statement of the Heart Failure Association and the European Heart Rhythm Association of the ESC is a joint effort to summarize the current literature and provide advice on patient management within this field.

Original language	English
Pages (from-to)	808-821
Number of pages	14
Journal	European Journal of Heart Failure
Volume	27
Issue number	5
Early online date	1 Apr 2025
DOIs	https://doi.org/10.1002/ejhf.3635
State	Published - May 2025
Externally published	Yes

Bibliographical note

Publisher Copyright:
© 2025 European Society of Cardiology.

Keywords

Cardiac implantable electronic device
Cardiac resynchronization therapy
Left ventricular assist device
Pacemaker
Remote monitoring

Access to Document

10.1002/ejhf.3635

Fingerprint

Dive into the research topics of 'Cardiac implantable electronic and other monitoring devices in continuous-flow left ventricular assist device patients. A clinical consensus statement of the Heart Failure Association and the European Heart Rhythm Association of the ESC'. Together they form a unique fingerprint.

Cite this

Amir, O., Adamopoulos, S., Burri, H., Bayes-Genis, A., Leclercq, C., Cikes, M., Egorova, A., Peichl, P., Fudim, M., Rao, A., Gustafsson, F., Richter, S., Pagnesi, M., Rosano, G., Ruschitzka, F., & Nielsen, J. C. (2025). Cardiac implantable electronic and other monitoring devices in continuous-flow left ventricular assist device patients. A clinical consensus statement of the Heart Failure Association and the European Heart Rhythm Association of the ESC. European Journal of Heart Failure, 27(5), 808-821. https://doi.org/10.1002/ejhf.3635

Amir, Offer ; Adamopoulos, Stamatis ; Burri, Haran et al. / Cardiac implantable electronic and other monitoring devices in continuous-flow left ventricular assist device patients. A clinical consensus statement of the Heart Failure Association and the European Heart Rhythm Association of the ESC. In: European Journal of Heart Failure. 2025 ; Vol. 27, No. 5. pp. 808-821.

@article{126e8fb08df849f2811e1d2685376ca2,

title = "Cardiac implantable electronic and other monitoring devices in continuous-flow left ventricular assist device patients. A clinical consensus statement of the Heart Failure Association and the European Heart Rhythm Association of the ESC",

abstract = "The management of heart failure patients with continuous-flow left ventricular assist device (LVAD) patients is challenging. While one third of these patients are recipients of cardiac implantable electronic devices (CIEDs), the risk for atrial and ventricular arrhythmias may coexist. The lack of large datasets and dedicated randomized controlled trials (RCTs) focusing on LVAD and CIED implantation and management has brought medical centres to develop their own protocols and guidelines. This clinical consensus statement of the Heart Failure Association and the European Heart Rhythm Association of the ESC is a joint effort to summarize the current literature and provide advice on patient management within this field.",

keywords = "Cardiac implantable electronic device, Cardiac resynchronization therapy, Left ventricular assist device, Pacemaker, Remote monitoring",

author = "Offer Amir and Stamatis Adamopoulos and Haran Burri and Antoni Bayes-Genis and Christophe Leclercq and Maja Cikes and Anastasia Egorova and Petr Peichl and Marat Fudim and Archana Rao and Finn Gustafsson and Sergio Richter and Matteo Pagnesi and Giuseppe Rosano and Frank Ruschitzka and Nielsen, \{Jens Cosedis\}",

note = "Publisher Copyright: {\textcopyright} 2025 European Society of Cardiology.",

year = "2025",

month = may,

doi = "10.1002/ejhf.3635",

language = "אנגלית",

volume = "27",

pages = "808--821",

journal = "European Journal of Heart Failure",

issn = "1388-9842",

publisher = "John Wiley and Sons Ltd",

number = "5",

}

Amir, O, Adamopoulos, S, Burri, H, Bayes-Genis, A, Leclercq, C, Cikes, M, Egorova, A, Peichl, P, Fudim, M, Rao, A, Gustafsson, F, Richter, S, Pagnesi, M, Rosano, G, Ruschitzka, F & Nielsen, JC 2025, 'Cardiac implantable electronic and other monitoring devices in continuous-flow left ventricular assist device patients. A clinical consensus statement of the Heart Failure Association and the European Heart Rhythm Association of the ESC', European Journal of Heart Failure, vol. 27, no. 5, pp. 808-821. https://doi.org/10.1002/ejhf.3635

Cardiac implantable electronic and other monitoring devices in continuous-flow left ventricular assist device patients. A clinical consensus statement of the Heart Failure Association and the European Heart Rhythm Association of the ESC. / Amir, Offer; Adamopoulos, Stamatis; Burri, Haran et al.
In: European Journal of Heart Failure, Vol. 27, No. 5, 05.2025, p. 808-821.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Cardiac implantable electronic and other monitoring devices in continuous-flow left ventricular assist device patients. A clinical consensus statement of the Heart Failure Association and the European Heart Rhythm Association of the ESC

AU - Amir, Offer

AU - Adamopoulos, Stamatis

AU - Burri, Haran

AU - Bayes-Genis, Antoni

AU - Leclercq, Christophe

AU - Cikes, Maja

AU - Egorova, Anastasia

AU - Peichl, Petr

AU - Fudim, Marat

AU - Rao, Archana

AU - Gustafsson, Finn

AU - Richter, Sergio

AU - Pagnesi, Matteo

AU - Rosano, Giuseppe

AU - Ruschitzka, Frank

AU - Nielsen, Jens Cosedis

PY - 2025/5

Y1 - 2025/5

N2 - The management of heart failure patients with continuous-flow left ventricular assist device (LVAD) patients is challenging. While one third of these patients are recipients of cardiac implantable electronic devices (CIEDs), the risk for atrial and ventricular arrhythmias may coexist. The lack of large datasets and dedicated randomized controlled trials (RCTs) focusing on LVAD and CIED implantation and management has brought medical centres to develop their own protocols and guidelines. This clinical consensus statement of the Heart Failure Association and the European Heart Rhythm Association of the ESC is a joint effort to summarize the current literature and provide advice on patient management within this field.

AB - The management of heart failure patients with continuous-flow left ventricular assist device (LVAD) patients is challenging. While one third of these patients are recipients of cardiac implantable electronic devices (CIEDs), the risk for atrial and ventricular arrhythmias may coexist. The lack of large datasets and dedicated randomized controlled trials (RCTs) focusing on LVAD and CIED implantation and management has brought medical centres to develop their own protocols and guidelines. This clinical consensus statement of the Heart Failure Association and the European Heart Rhythm Association of the ESC is a joint effort to summarize the current literature and provide advice on patient management within this field.

KW - Cardiac implantable electronic device

KW - Cardiac resynchronization therapy

KW - Left ventricular assist device

KW - Pacemaker

KW - Remote monitoring

UR - https://www.scopus.com/pages/publications/105002078105

U2 - 10.1002/ejhf.3635

DO - 10.1002/ejhf.3635

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 40170454

AN - SCOPUS:105002078105

SN - 1388-9842

VL - 27

SP - 808

EP - 821

JO - European Journal of Heart Failure

JF - European Journal of Heart Failure

IS - 5

ER -

Amir O, Adamopoulos S, Burri H, Bayes-Genis A, Leclercq C, Cikes M et al. Cardiac implantable electronic and other monitoring devices in continuous-flow left ventricular assist device patients. A clinical consensus statement of the Heart Failure Association and the European Heart Rhythm Association of the ESC. European Journal of Heart Failure. 2025 May;27(5):808-821. Epub 2025 Apr 1. doi: 10.1002/ejhf.3635

Cardiac implantable electronic and other monitoring devices in continuous-flow left ventricular assist device patients. A clinical consensus statement of the Heart Failure Association and the European Heart Rhythm Association of the ESC

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this